Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.112450
Revised: September 12, 2025
Accepted: October 22, 2025
Published online: January 19, 2026
Processing time: 156 Days and 11 Hours
Postoperative delirium (POD) is a common and serious complication in surgical patients, particularly older adults. Alterations in cholinergic function have been implicated in its pathophysiology.
To evaluate the association between preoperative serum cholinesterase (ChE) activity—specifically butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE)—and the risk of POD in adult surgical patients in a meta-analysis.
A systematic search was conducted in PubMed, EMBASE, and Web of Science up to March 28, 2025 for studies reporting preoperative serum BuChE or AChE activity in relation to subsequent POD incidence. Standardized mean differences (SMDs) and odds ratios (ORs) with 95% confidence intervals (CIs) were pooled using random-effects models. Subgroup and sensitivity analyses were performed based on follow-up duration and analytic models.
Thirteen studies (n = 2730 patients) were included. Patients who developed POD had significantly lower preoperative BuChE activity than those who did not (SMD = -0.28; 95%CI: -0.39 to -0.16; I² = 18%). Higher BuChE activity was associated with a reduced risk of POD (OR per 100 unit increment = 0.97; 95%CI: 0.95-0.99; I2 = 0%). In contrast, pooled AChE activity did not differ significantly between POD and non-POD groups (SMD = -0.25; 95%CI: -0.53 to 0.03; P = 0.08; I2 = 80%), and the ORs per 1 unit increment in AChE activity were not statistically significant (OR = 0.98; 95%CI: 0.95-1.01).
Lower preoperative serum BuChE activity is associated with an increased risk of POD in adults undergoing surgery. BuChE activity may serve as a potential preo
Core Tip: This meta-analysis synthesizes evidence from 13 studies involving 2730 surgical patients to assess the association between preoperative cholinesterase activity and postoperative delirium (POD). We found that lower preoperative butyrylcholinesterase (BuChE) activity was significantly associated with increased POD risk, whereas acetylcholinesterase activity showed no consistent association. These findings suggest that serum BuChE may serve as a simple, accessible biomarker for POD risk stratification. Our study provides the most comprehensive evidence to date linking peripheral cholinergic dysfunction to POD and highlights BuChE as a potential target for early identification and intervention.
